Abstract
Background. Non-Hodgkin lymphomas are clinically and molecularly heterogeneous diseases. In addition to clinical symptoms, morphology and immunophenotype, molecular diagnostics are increasingly used to more accurately classify lymphomas into homogeneous, clinically relevant and non-overlapping entities. Conclusion. Molecular classifiers are used to improve the diagnostic accuracy of entities, to detect the biological heterogeneity in an entity in more detail and to develop prognostic and/or predictive biomarkers. This article reviews the recent developments in molecular classifiers focusing on follicular lymphoma and diffuse large B-cell lymphoma.
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 0947-8965 |
| Language: | German |
| Item ID: | 78940 |
| Date Deposited: | 15. Dec 2021 14:46 |
| Last Modified: | 15. Dec 2021 14:46 |
Actions (login required)
- View Item
